Phenoperidine

From WikiMD's WELLNESSPEDIA

File:Phenoperidine.svg
Phenoperidine.svg

Phenoperidine is a synthetic opioid analgesic that is structurally related to pethidine (meperidine). It was first synthesized in the 1950s and has been used primarily in Europe for the management of moderate to severe pain, particularly in a surgical setting.

Pharmacology[edit]

Phenoperidine acts on the central nervous system (CNS) by binding to opioid receptors, which are part of the body's endogenous pain control system. This binding results in analgesia, sedation, and a sense of well-being. Like other opioids, phenoperidine can cause respiratory depression, which is a significant risk factor in its use.

Medical Uses[edit]

Phenoperidine is used for its potent analgesic properties. It is often administered in a hospital setting, particularly during and after surgery to manage pain. Its use is less common in chronic pain management due to the risk of tolerance and dependence.

Side Effects[edit]

The side effects of phenoperidine are similar to those of other opioids and can include:

Contraindications[edit]

Phenoperidine should not be used in patients with a history of opioid addiction, severe asthma, or respiratory insufficiency. It should be used with caution in patients with head injury or increased intracranial pressure.

Legal Status[edit]

The legal status of phenoperidine varies by country. In many places, it is classified as a controlled substance due to its potential for abuse and dependence.

History[edit]

Phenoperidine was developed in the 1950s as part of a search for new synthetic opioids that could provide effective pain relief with fewer side effects than morphine. It has been used primarily in Europe and has seen limited use in other parts of the world.

See Also[edit]

References[edit]


External Links[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.